Cargando…
OR26-05 Long-term Mortality And Cardiometabolic Effects Of Treatment For Hyperthyroidism: EGRET Study
Disclosure: B. Torlinska: None. J.M. Hazlehurst: None. K. Nirantharakumar: None. G. Thomas: None. P. Julia: None. K.R. Abrams: None. K. Boelaert: None. Objectives: Hyperthyroidism has been linked to long-term cardiovascular and metabolic morbidity and increased mortality. Current evidence indicates...
Autores principales: | Torlinska, Barbara, Hazlehurst, Jonathan Mark, Nirantharakumar, Krishnarajah, Neil Thomas, G, Julia, Priestley, Abrams, Keith R, Boelaert, Kristien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554780/ http://dx.doi.org/10.1210/jendso/bvad114.2053 |
Ejemplares similares
-
wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD–HES linked cohort study
por: Torlinska, Barbara, et al.
Publicado: (2021) -
SUN-506 Hyperthyroidism Induced Hepatic Apoptosis
por: Ahmed, Sabreen, et al.
Publicado: (2020) -
ODP655 Apathetic Hyperthyroidism
por: Seetharaman, Kavita
Publicado: (2022) -
SUN-572 Hyperthyroidism Refractory to Methimazole
por: Eren, Aysegul, et al.
Publicado: (2019) -
The Grave Hematologic and Hepatic Effects of Hyperthyroidism
por: Ahmad, Sara Miriam, et al.
Publicado: (2021)